Cargando…
DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours
The p16 (CDKN2/MTS-1/INK4A) gene is one of several tumour-suppressor genes that have been shown to be inactivated by DNA methylation in various human cancers including breast tumours. We have used bisulphite genomic sequencing to examine the detailed sequence specificity of DNA methylation in the Cp...
Autores principales: | Woodcock, D M, Linsenmeyer, M E, Doherty, J P, Warren, W D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362189/ https://www.ncbi.nlm.nih.gov/pubmed/9888465 http://dx.doi.org/10.1038/sj.bjc.6690041 |
Ejemplares similares
-
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
por: Schuyer, M., et al.
Publicado: (1996) -
Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997) -
A High Prevalence of Functional Inactivation by Methylation Modification of p16(INK4A)/CDKN2/MTS1 Gene in Primary Urothelial Cancers
por: Akao, Toshiya, et al.
Publicado: (1997) -
Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1995) -
Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients
por: Silva, J M, et al.
Publicado: (1999)